Fresenius Renal Therapies Announces the Introduction of Next Generation Sentinel Technology to Support Fluid Management Challenges in the End Stage Renal Disease Community

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. MU
8. PFE
9. ACN
10. USO

Go back to Fresenius Renal Therapies Announces the Introduction of Next Generation Sentinel Technology to Support Fluid Management Challenges in the End Stage Renal Disease Community

Fresenius Medical Care (FMS) Tops Q1 EPS by 33c

May 3, 2016 8:53 AM EDT

Fresenius Medical Care (NYSE: FMS) reported Q1 EPS of $0.75, $0.33 better than the analyst estimate of $0.42. Revenue for the quarter came in at $4.21 billion versus the consensus estimate of $4.25 billion.Fresenius Medical Care reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Fresenius Medical Care (FMS) click here.

... More